Disclaimer: This site aggregates publicly available data from official government sources (FDA, ClinicalTrials.gov, PubMed, SEC EDGAR, NMPA) for general reference only. It does NOT constitute medical advice, diagnosis, treatment recommendations, or investment advice.

Clinical Trial

Neuromodulation of Different Doses to Treat TRD Guided by pBFS Technique

NCT: NCT06112652 · SUSPENDED

NCT IDNCT06112652
StatusSUSPENDED
Start Date2023-12-04
Completion2026-12-30

Brief Summary

The aim of this study is to explore the effectiveness and safety of different doses of neural regulation under the guidance of pBFS technology in improving symptoms in patients with moderate to severe depressive disorders.

Frequently Asked Questions

What is Neuromodulation of Different Doses to Treat TRD Guided by pBFS Technique?

Neuromodulation of Different Doses to Treat TRD Guided by pBFS Technique is a clinical trial registered under NCT06112652. Current status: SUSPENDED.

What is the status of NCT06112652?

The current status of NCT06112652 (Neuromodulation of Different Doses to Treat TRD Guided by pBFS Technique) is: SUSPENDED.

When did Neuromodulation of Different Doses to Treat TRD Guided by pBFS Technique start?

Neuromodulation of Different Doses to Treat TRD Guided by pBFS Technique started on 2023-12-04.

Official Source

View on ClinicalTrials.gov →

Data sourced from ClinicalTrials.gov API. For the most current status, refer to the official record.

↑